AU Patent

AU2009223061B2 — Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

Assigned to Assertio Holdings Inc · Expires 2014-10-09 · 12y expired

What this patent protects

Compositions and methods for the treatment of pain in a mammal are described. More specifically, a dosage form designed for release of acetaminophen and an opioid is described, wherein the dosage form provides delivery of the drugs to the upper gastrointestinal tract ("Gl&#34…

USPTO Abstract

Compositions and methods for the treatment of pain in a mammal are described. More specifically, a dosage form designed for release of acetaminophen and an opioid is described, wherein the dosage form provides delivery of the drugs to the upper gastrointestinal tract ("Gl") of a mammal for an extended period of time

Drugs covered by this patent

Patent Metadata

Patent number
AU2009223061B2
Jurisdiction
AU
Classification
—
Expires
2014-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Assertio Holdings Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.